Stay updated on VB-111 Combo in Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 57 locations, and the revision has been updated from v2.9.7 to v2.10.0.
    Difference
    0.4%
    Check dated 2024-07-23T15:24:45.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:35:36.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:11:13.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T10:07:49.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:58:11.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The recent change in the webpage value from 'Show more Revision: v2.9.0' to 'Genetic and Rare Diseases Information Center resources: Glioblastoma, Glioma, Neuroepithelioma, Drug Information available for: Bevacizumab, FDA Drug and Device Resources' represents an update in the study details section, specifically highlighting additional resources and information related to the treatment options and diseases covered in the clinical trial.
    Difference
    14%
    Check dated 2024-06-25T08:30:04.000Z thumbnail image

Stay in the know with updates to VB-111 Combo in Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.